Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
TLT.V - Theralase Technologies Inc
Q3 2024 Theralase Technologies Inc Earnings Call
Dec 04, 2024 / 04:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning everyone. My name is Matthew Perten and I'll be hosting thela Technology Inc quarterly investor conference call. Today.
The focus of today's call will be a presentation and discussion of the company's third quarter, 2024 interim financial statements and an update on the phase two bladder cancer clinical study.
Following each presentation, there will be a question and answer session. The agenda for today's call. Firstly, Christina Hatchie, Chief Financial Officer will present the third quarter, interim financial statements followed by a Q&A session the results afterwards. Roger Duan White President and CEO will provide an update on the phase two bladder cancer clinical study which will also